Dobutamine: a new synthetic cardioactive sympathetic amine.
about
Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogsRelation between regional function and coronary blood flow reserve in multivessel coronary artery stenosis.Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.Congestive heart failure. New frontiersInotropes do not increase mortality in advanced heart failureThe effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.New Drugs. Beta-blockers and sympathomimeticsMyocardial perfusion scintigraphy: techniques, interpretation, indications and reporting.Septic shock and sepsis syndrome in obstetric patientsManagement of the pediatric patient after cardiac surgerySelectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding.The role of dopaminergic agents and the dopamine receptor in treatment for CHF.Dobutamine: ten years later.An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).Structures reveal details of small molecule binding to cardiac troponin.Inotropic drugs for the treatment of heart failure.Review of intermittent dobutamine infusions for congestive cardiomyopathy.Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.Differential effects of (+/-)-dobutamine and human alpha-CGRP on cardiac and on regional haemodynamics in conscious Long Evans rats.Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.Differential effects of OPC-18790, amrinone and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart.Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications.Effects of beta-adrenoceptor ligands in the elevated X-maze 'anxiety' model and antagonism of the 'anxiogenic' response to 8-OH-DPAT.Decreased left ventricular contractility reserve in patients with never-treated essential hypertension.Intravenous inotropic agents in heart failure.Effects of dopamine and dobutamine on the myocardial and systemic circulation during and following cardiopulmonary bypass in dogs.
P2860
Q24673440-2087D7B7-B328-4302-B45B-6259294A5E8FQ30306431-29336FDD-CDBE-4FB4-81B5-FBF0DDF30C3BQ33458068-8F07A9AA-3136-4EDD-B1DD-7B7BA80112B2Q33559075-B03E2E8B-2611-45F1-8AE9-F65AA66CDA1AQ33685748-79C2DB56-B1FB-431E-A46D-7B4640FA8A3EQ34776831-99AEF4D1-C842-4A16-9997-218EE4AF9E65Q34992071-9B391284-1C44-4561-BEF4-DBF368B4337EQ35564413-A1D21584-5795-45D3-99FC-0BFCAA87CA77Q36624675-F19B6C98-689B-4616-9C07-2929D01DF72DQ36988494-33A17C43-81FF-4E9D-B339-AA14C6D27BC9Q37000137-730A808B-DED4-4A46-A222-42273E0A9886Q38349703-E77C7637-16C0-4B54-9DDD-6E78225847CEQ38683788-9B6B7A95-7322-4044-9A01-55E0782A24C3Q38973132-A44BF57E-B027-4D0B-A560-48B05BF3E2ABQ39003251-1CBABCCC-4A89-4BDC-9C51-BDEB6CF9B817Q39405022-CEBA4CC1-E038-40DA-80F8-E2540CBFCFE5Q39660139-DBEE7EE5-5833-4BE3-947D-864F8C8324BEQ40690111-A24D3C50-04D0-4D0A-A26C-415AC378DF27Q41300220-1CFE1729-B70E-438A-8C6D-7845721EF937Q41940821-74E4FDFC-6EC8-4A2F-B832-1AF65B089ABDQ41992744-FA85FFD2-F144-46D9-B9B1-E9D2DA581A2DQ42114866-2F76D1BB-E1CD-444C-905F-E103B4493614Q43867413-6B323445-94A9-4658-A301-7CCE9FA5443DQ46941106-AAF84687-7DA1-4C82-858C-4AAA9A644E68Q52071773-0DC2EC40-0270-415A-AC2E-951690D0A12DQ54029634-D937A10D-2F23-40F4-AC30-8773DD157D92Q54523028-8E44B3E2-6CB8-4AAA-8152-CFB8017B05C4
P2860
Dobutamine: a new synthetic cardioactive sympathetic amine.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Dobutamine: a new synthetic cardioactive sympathetic amine.
@en
Dobutamine: a new synthetic cardioactive sympathetic amine.
@nl
type
label
Dobutamine: a new synthetic cardioactive sympathetic amine.
@en
Dobutamine: a new synthetic cardioactive sympathetic amine.
@nl
prefLabel
Dobutamine: a new synthetic cardioactive sympathetic amine.
@en
Dobutamine: a new synthetic cardioactive sympathetic amine.
@nl
P2093
P1476
Dobutamine: a new synthetic cardioactive sympathetic amine.
@en
P2093
Frishman WH
LeJemtel TH
Sonnenblick EH
P356
10.1056/NEJM197901043000105
P407
P577
1979-01-01T00:00:00Z